Biogen Inc. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.Biogen Inc. (BIIB) shares rose 2.76% to $197.24, outperforming competitors like Johnson & Johnson and Pfizer on a strong trading day. The stock closed 10.23% below its 52-week high, with trading volume of 2.1 million eclipsing the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. (BIIB) rose 2.76% to $197.24 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.38% to 7,572.40 and the Dow Jones Industrial Average rising 0.29% to 52,658.64.
Biogen Inc. closed 10.23% below its 52-week high of $219.72, which the company reached on June 29th.
The stock outperformed some of its competitors Wednesday, as Johnson & Johnson (JNJ) fell 2.69% to $247.02, Pfizer Inc. (PFE) rose 2.35% to $24.82, and AbbVie Inc. (ABBV) rose 0.44% to $244.11.
Trading volume (2.1 M) eclipsed its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 15, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-15-26 1658ET